[Effect of phospholipids on mebendazole pharmacokinetics in experimental multilocular echinococcosis].
D000284:Administration, Oral; D000818:Animals; D001682:Biological Availability; D004353:Drug Evaluation, Preclinical; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004443:Echinococcosis / Q000188:drug therapy / Q000378:metabolism*; D007273:Injections, Intramuscular; D007700:Kinetics; D008463:Mebendazole / Q000008:administration & dosage / Q000378:metabolism*; D051379:Mice; D008808:Mice, Inbred CBA; D010713:Phosphatidylcholines / Q000008:administration & dosage / Q000378:metabolism; D010743:Phospholipids / Q000008:administration & dosage / Q000378:metabolism*
D010713:Phosphatidylcholines; D010743:Phospholipids; C011246:essential 303 forte; D008463:Mebendazole
Vliianie fosfolipidov na farmakokinetiku mebendazola pri éksperimental'nom mnogokamernom ékhinokokkoze.